Balyasny Asset Management
GNCA

Balyasny Asset Management’s Genocea Biosciences, Inc. GNCA Stock Holding History

Balyasny Asset Management’s Portfolio GNCA Stock Details GNCA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$145K Sell
2017
Q4 		$254K Buy
2017
Q3 		$158K Buy
2016
Q3 		– Sell
2016
Q2 		$44K Buy
2016
Q1 		– Sell
2015
Q4 		$58K Buy